No Data
No Data
H.C. Wainwright Maintains Cidara Therapeutics(CDTX.US) With Buy Rating, Maintains Target Price $24
Express News | HC Wainwright & Co. Reiterates Buy on Cidara Therapeutics, Maintains $24 Price Target
Cidara Therapeutics to Cut 30% Workforce; Shares Down After-Hours
Express News | Cidara Therapeutics Inc: Expects to Initiate Phase 2B Clinical Trial of Cd388 for Prevention of Influenza in Q3 2024
Express News | Cidara Therapeutics- Estimates Will Incur Charges of About $1.2 Mln for Severance Payments and Employee Benefits, Primarily in Q4 2024
Express News | Cidara Therapeutics Inc: Continues Business Development Discussions for Its Oncology Dfc Programs